Nxera Pharma Co., Ltd. (TYO: 4565)
Japan
· Delayed Price · Currency is JPY 1,202.00
+8.00 (0.67%)
Nov 12, 2024, 3:40 PM JST
Nxera Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -3,711 | -10,680 | 1,078 | 433 | 1,622 | 534 | Upgrade
|
| Depreciation & Amortization | 3,963 | 2,478 | 1,345 | 1,278 | 1,350 | 1,489 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 3,138 | - | 613 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,363 | 1,363 | 1,877 | -208 | -111 | -59 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 429 | -50 | 356 | 181 | Upgrade
|
| Other Operating Activities | -2,903 | -942 | 338 | 486 | 1,325 | 1,016 | Upgrade
|
| Change in Accounts Receivable | 1,315 | 1,315 | -210 | -799 | 752 | -923 | Upgrade
|
| Change in Inventory | 2,365 | 1,908 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | -1,829 | 1,552 | 315 | -184 | 61 | -258 | Upgrade
|
| Change in Other Net Operating Assets | -621 | -2,267 | 4,780 | 3,001 | -683 | 848 | Upgrade
|
| Operating Cash Flow | 2,425 | -5,273 | 9,952 | 7,095 | 4,672 | 3,441 | Upgrade
|
| Operating Cash Flow Growth | 271.36% | - | 40.27% | 51.86% | 35.77% | - | Upgrade
|
| Capital Expenditures | -683 | -804 | -277 | -193 | -92 | -271 | Upgrade
|
| Cash Acquisitions | -513 | -62,941 | - | - | - | - | Upgrade
|
| Divestitures | - | - | - | 206 | -577 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -37 | -47 | -26 | -8 | -13 | -9 | Upgrade
|
| Investment in Securities | - | - | 1,209 | - | 238 | -250 | Upgrade
|
| Other Investing Activities | 564 | 1 | 137 | 273 | 294 | 284 | Upgrade
|
| Investing Cash Flow | -669 | -63,791 | 1,043 | 278 | -150 | -246 | Upgrade
|
| Long-Term Debt Issued | - | 71,608 | - | 29,855 | 15,902 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1,450 | - | - | - | -7,061 | Upgrade
|
| Total Debt Repaid | -38,121 | -1,450 | - | - | - | -7,061 | Upgrade
|
| Net Debt Issued (Repaid) | -6,413 | 70,158 | - | 29,855 | 15,902 | -7,061 | Upgrade
|
| Issuance of Common Stock | 9,983 | 9,983 | - | 600 | 5,145 | 747 | Upgrade
|
| Other Financing Activities | -17 | -31,812 | -4,887 | -19,332 | -769 | -650 | Upgrade
|
| Financing Cash Flow | 3,553 | 48,329 | -4,887 | 11,123 | 20,278 | -6,964 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,173 | 3,243 | 362 | 1,583 | -167 | 384 | Upgrade
|
| Net Cash Flow | 6,482 | -17,492 | 6,470 | 20,079 | 24,633 | -3,385 | Upgrade
|
| Free Cash Flow | 1,742 | -6,077 | 9,675 | 6,902 | 4,580 | 3,170 | Upgrade
|
| Free Cash Flow Growth | 1998.80% | - | 40.18% | 50.70% | 44.48% | - | Upgrade
|
| Free Cash Flow Margin | 5.95% | -47.60% | 62.14% | 38.97% | 51.80% | 32.59% | Upgrade
|
| Free Cash Flow Per Share | 19.76 | -73.65 | 117.14 | 84.16 | 57.61 | 40.91 | Upgrade
|
| Cash Interest Paid | 382 | 241 | 171 | 157 | 60 | 103 | Upgrade
|
| Cash Income Tax Paid | 247 | 1,394 | 262 | -87 | -1,170 | -793 | Upgrade
|
| Levered Free Cash Flow | 4,600 | -11,530 | -1,367 | 8,544 | 4,514 | 681.13 | Upgrade
|
| Unlevered Free Cash Flow | 5,980 | -11,038 | -946.5 | 8,868 | 4,644 | 818 | Upgrade
|
| Change in Net Working Capital | -2,252 | 6,166 | 3,746 | -3,472 | -2,865 | 991 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.